The North America Bovine Lactoferrin Market would witness market growth of 8.1% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 81.6 Tonnes, showcasing a growth of 8.9% (2019-2022).
The robust scientific research backing the health benefits of bovine lactoferrin has played a pivotal role in driving its adoption. Studies highlighting its immune-regulating properties, antimicrobial effects, and role in iron absorption have instilled confidence among consumers and garnered the attention of healthcare professionals and formulators. This scientific validation has catalysed the integration of bovine lactoferrin into various products. Health professionals, including nutritionists, paediatricians, and general practitioners, have increasingly endorsed the inclusion of bovine lactoferrin in dietary plans. The recognition of its role in supporting the immune system, especially in vulnerable populations such as infants and older people, has led to healthcare practitioners recommending products containing bovine lactoferrin.
The adoption of bovine lactoferrin has been prominently observed in the functional food and beverage industry. Manufacturers recognize the potential of incorporating bovine lactoferrin into a broader range of products, including energy bars, yogurt, and beverages, to enhance their nutritional profiles. This diversification has widened the consumer base for bovine lactoferrin-containing products. The market has responded to consumer demands by diversifying product offerings that contain bovine lactoferrin. From traditional supplements to innovative formulations in functional foods and beverages, the diverse range of products has fuelled adoption across different demographics and consumer preferences.
According to the Centers for Disease Control and Prevention, six out of ten Americans suffer from at least one chronic condition, including diabetes, cancer, heart disease, or a stroke. The leading causes of death and disability in the US are these and other chronic disorders, dramatically raising healthcare costs. The prevalence of chronic diseases, including cardiovascular diseases, diabetes, and neurodegenerative conditions, continues to rise in America. Hence, the factors mentioned above will drive the regional market growth.
The US market dominated the North America Bovine Lactoferrin Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $138,024.6 Thousands by 2030. The Canada market is experiencing a CAGR of 10.5% during (2023 - 2030). Additionally, The Mexico market would register a CAGR of 9.5% during (2023 - 2030).
Free Valuable Insights: The Bovine Lactoferrin Market is Predict to reach $716 Million by 2030, at a CAGR of 8.5%
Based on Application, the market is segmented into Infant Formula, Dietary Supplements, Pharmaceutical, and Others. Based on Product Type, the market is segmented into Freeze-dried and Spray-dried. Based on Function, the market is segmented into Iron Absorption, Antibacterial, Immune Cell Stimulation and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
By Application (Volume, Tonnes, USD Million, 2019-2030)
By Product Type (Volume, Tonnes, USD Million, 2019-2030)
By Function (Volume, Tonnes, USD Million, 2019-2030)
By Country (Volume, Tonnes, USD Million, 2019-2030)
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
